Canaccord Adams
http://www.canaccordadams.com/default.htmCanaccord Adams is a leading independent financial services firm committed to fostering the entrepreneurial economy by bringing corporate and institutional clients unique perspective on global investment opportunities. With operations in research, sales and trading, and investment banking, their 225 professionals seek out emerging opportunities in their key sectors - Mining and Metals, Energy, Technology, Life Sciences, Real Estate and Gaming, Consumer and Industrial Growth. Located in nine offices internationally, their experienced team generates focused, actionable ideas that identify opportunity and facilitate growth.
View Older Stories View More Recent Stories
-
David Moenning's Daily State of the Markets: Losing Their Appetite?
-
Canaccords Adams Says Buy Research In Motion (RIMM) On Weakness
-
Headwaters (HW) Closes 9.6M Share Offering, Raising $34.5M in Net Proceeds
-
Google (GOOG) Clears $500 Hurdle
-
David Moenning's Daily State of the Markets: Strike Oneā¦
-
Canaccord Adams Raises Price Target on IAC/InterActiveCorp. (IACI) to $22, Sees More Share Buybacks
-
Canaccord Adams Starts HeartWare International (HTWR) at Buy
-
Canaccord Adams Starts Protalix BioTherapeutics (PLX) at Buy
-
Canaccord Adams Raises Price Target On Google (GOOG) to $560
-
Canaccord Adams Upgrades Magma Design (LAVA) to Buy
-
Morning Movers 9/18: BPFH, IOC, HEAT, LAVA, EROC Higher; FSP, ARNA, EDR, NMM Lower
-
Canaccord Adams Upgrades Rubicon Technology (RBCN) to Buy, Doubles Price Target
-
Omeros (OMER) Sees IPO Price of $10-$12
-
Canaccord Adams Transitions Coverage to a 'Hold' on Standard Microsystems (SMSC); Issues Q3 and FY'10 Estimates
-
Canaccord Adams Reiterates a 'Sell' on Palm (PALM); Valuation Too Rich
-
Canaccord Adams Reinstates a 'Buy' Rating on EnCana Corporation (ECA)
-
Headwaters (HW) Agrees to Sell 9.6M Shares at $3.90
-
Canaccord Adams Downgrades Omniture (OMTR) to Hold
-
Canaccord Adams Upgrades Emulex (ELX) to Buy
-
Canaccord Adams Upgrades Spectranetics (SPNC) to Buy
-
Canaccord Adams Reiterates a 'Buy' on National Semiconductor (NSM); Raises Price Target & Estimates
-
Canaccord Adams Reiterates a 'Buy' on Texas Instruments (TXN); Upside on High Performance Analog
-
NeuroMetrix (NURO) Announces Commitments from Institutional Investors to Buy $18.68M in Common Shares
-
Notable Analyst Rating Changes 9/2: TXT, CBE, SI, PAY, BBD Upgraded; ROK, GIS, HOLX, DHI, RYL, NVAX Downgraded
-
Canaccord Adams Initiates Coverage on Kadant (KAI) with a Buy
-
Canaccord Adams Downgrades Hologic (HOLX) to Hold
-
Unusual 11 Mid-Day Movers 8/26: NYMX, VG, SOMX, USEG Higher; CASM, CCUR, ISLE, DY Lower
-
David Moenning's Daily State of the Markets: 8/26
-
Morning Movers 8/26: VG, GSAT, HGSI, MYGN Higher; CCUR, CASM, ISLE, BPI Lower
-
Canaccord Adams Downgrades Netezza (NZ) to Hold
-
Canaccord Adams Upgrades Myriad Genetics (MYGN) to Buy
-
Canaccord Adams Initiates Coverage on St. Mary Land & Exploration (SM) with a Hold
-
Canaccord Adams Initiates Covearge on Rex Energy (REXX) with a Buy
-
Canaccord Adams Initiates Coverage on Northern Oil and Gas (NOG) with a Buy
-
Canaccord Adams Initiates Coverage on Whiting Petroleum (WLL) with a Buy
-
Canaccord Adams Initiates Coverage on Encore Acquisition Company (EAC)
-
Canaccord Adams Initiates Coverage on Brigham Exploration (BEXP)
-
Canaccord Adams Calls Onyx Phama (ONXX) A Top 2nd-Half Pick
-
EnerNOC (ENOC) Raises Additional $5.5 Million From Common Stock Offering
-
Canaccord Adams Downgrades AEterna Zentaris (AEZS) to Speculative Buy; Negative Phase III Study Results
-
Canaccord Adams Upgrades ArthroCare (ARTC) to Buy; Positive on Equity Investment
-
Canaccord Adams Maintains a 'Buy' on NetApp (NTAP); Raises Price Target Ahead of Earnings Report
-
Canaccord Adams Initiates Coverage on Motorola (MOT) with a Buy; Successfully Stabilized its Handset Business
-
Metalico (MEA) Sold 6M Shares Raising $25M
-
Cubist Pharmaceuticals (CBST) September volatility at 52
-
Green Mountain Coffee (GMCR) Prices 5M Shares at $67.25
-
EnerNOC (ENOC) Prices 3.75M Shares Offering at $27
-
Canaccord Adams Starts Monsanto (MON) at Hold, Glyphosate Sales to be Worse Than Expected
-
Canaccord Adams Maintains a 'Buy' on Wright Medical Group (WMGI); Inexpensive Longer-Term
-
Canaccord Adams Maintains a 'Buy' on DexCom (DXCM); Sees Increased Traction in CGM
